Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine

Psychopharmacology

Volumn 134, Issue 3, 1997, Pages 266-276

  Li, Yong ^a   Vartanian, A John ^a   White, Francis J ^a   Xue, Chang Jiang ^a   Wolf, Marina E ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

AMPA; Amphetamine; Behavioral sensitization; Cocaine; NBQX; Rat

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMPA RECEPTOR; AMPA RECEPTOR ANTAGONIST; AMPHETAMINE; COCAINE; GLUTAMATE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG EFFECT; LOCOMOTION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIZATION;

AMPHETAMINE; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, AMPA; STEREOTYPED BEHAVIOR;

EID: 0030684123     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050449     Document Type: Article

References (69)

1. Antelman SM, Chiodo LA (1981) Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis? Biol Psychiatry 16: 717-727
2. Burns LH, Everitt BJ, Kelley AE, Robbins TW (1994) Glutamatedopamine interactions in the ventral striatum: role in locomotor activity and responding with conditioned reinforcement. Psychopharmacology 115: 516-528
3. Cador M, Bjijou Y, Stinus L (1995) Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65: 385-395
4. Carey RJ, Dai H, Krost M, Huston MP (1995) The NMDA receptor and cocaine: evidence that MK-801 can induce behavioral sensitization effects. Pharmacol Biochem Behav 51: 901-908
5. Carlezon WA Jr, Mendrek A, Wise RA (1995) MK-801 disrupts the expression but not the development of bromocriptine sensitization: a state-dependency interpretation. Synapse 20: 1-9
6. Charara A, Smith Y, Parent A (1996) Glutamatergic inputs from the pedunculopontine nucleus to midbrain dopaminergic neurons in primates: Phaseolus vulgaris-leucoagglutinin anterograde labeling combined with postembedding glutamate and GABA immunohistochemistry. J Comp Neurol 364: 254-266
7. Criswell HE, Johnson KB, Mueller RA, Breese GR (1993) Evidence for involvement of brain dopamine and other mechanisms in the behavioral action of the N-methyl-D-aspartic acid antagonist MK-801 in control and 6-hydroxydopamine-lesioned rats. J Pharmacol Exp Ther 265: 1001-1010
8. Damianopoulos EN, Carey RJ (1995) Evidence for N-methyl-D-aspartate receptor mediation of cocaine induced corticosterone release and cocaine conditioned stimulant effects. Behav Brain Res 68: 219-228
9. Danysz W, Zajaczkowski W, Parsons CG (1995) Modulation of learning processes by ionotropic glutamate receptor ligands. Behav Pharmacol 6: 455-474
10. Di Loreto S, Florio T, Scarnati E (1992) Evidence that non-NMDA receptors are involved in the excitatory pathway from the pedunculopontine region to nigrostriatal dopaminergic neurons. Exp Brain Res 89: 79-86
11. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ (1996) Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16: 274-282
12. Fonnum F, Soreida A, Krale I, Walku J, Walaas I (1981) Glutamate in cortical fibers. Adv Biochem Pharmacol 27: 19-42
13. Freed WJ, Cannon-Spoor HE (1990) A possible role of AA2 excitatory amino acid receptors in the expression of stimulant drug effects. Psychopharmacology 101: 456-464
14. Gröenewegen HJ, Berendse HW (1990) Connections of the subthalamic nucleus with ventral striatopallidal parts of the basal ganglia in the rat. J Comp Neurol 294: 607-622
15. Haracz JL, Belanger SA, MacDonall JS, Sircar R (1995) Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci 57: 2347-2357
16. Henry DJ, White FJ (1995) The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15: 6287-6299
17. Ida I, Asami T, Kuribara H (1995) Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn J Pharmacol 69: 83-90
18. Jeziorski M, White FJ, Wolf ME (1994) MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16: 137-147
19. Kaddis FG, Wallace LJ, Uretsky NJ (1993) AMPA/kainate antagonists in the nucleus accumbens inhibit locomotor stimulatory response to cocaine and dopamine agonists. Pharmacol Biochem Behav 46: 803-808
20. Kalivas PW, Alesdatter JE (1993) Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267: 486-495
21. Kalivas PW, Weber B (1988) Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245: 1095-1102
22. Kamata K, Rebec GV (1983) Dopaminergic and neostriatal neurons: dose-dependent changes in sensitivity to amphetamine following long-term treatment. Neuropharmacology 22: 1377-1382
23. Karler R, Calder LD, Chaudhry IA, Turkanis SA (1989) Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45: 599-606
24. Karler R, Calder LD, Turkanis SA (1991) DNQX blockade of amphetamine behavioral sensitization. Brain Res 552: 295-300
25. Karler R, Calder LD, Bedingfield JB (1994) Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology 115: 305-310
26. Kelley AE, Delfs JM (1994) Excitatory amino acid receptors mediate the orofacial stereotypy elicited by dopaminergic stimulation of the ventrolateral striatum. Neuroscience 60: 85-95
27. Kitai ST, Kita H (1987) Anatomy and physiology of the subthalamic nucleus: a driving force of the basal ganglia. In: Carpenter MB, Jayarman A (eds) The basal ganglia II - structure and function: current concepts. Plenum Press, New York, pp 357-373
28. Kornhuber J, Kim JS, Kornhuber ME, Kornhuber HH (1984) The corticonigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat. Brain Res 322: 124-126
29. Lehmann J, Hutchison AJ, McPherson SE, Mondadori C, Schmutz M, Sinton CM, Tsai C, Murphy DE, Steel DJ, Williams M, Cheney DL, Wood PL (1988) CGS 19755, a selective and competitive N-methyl-D-aspartate-type excitatory amino acid receptor antagonist. J Pharmacol Exp Ther 246: 65-75
30. Leith NJ, Kuczenski R (1982) Two dissociable components of behavioral sensitization following repeated amphetamine administration. Psychopharmacology 76: 310-315
31. Li Y, Berney T, Stine C, Hu X-T, Wolf ME, White FJ (1995) Both NMDA receptor antagonists and prefrontal cortex lesions prevent VTA DA autoreceptor subsensitivity after repeated cocaine treatment. Soc Neurosci Abstr 21: 713
32. Lu W, Chen H, Xue C-J, Wolf ME (1997) Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse 26: 269-280
33. Namba T, Morimoto K, Sato K, Yamada N, Kuroda S (1994) Antiepileptogenic and anticonvulsant effects of NBQX. a selective AMPA receptor antagonist, in the rat kindling model of epilepsy. Brain Res 638: 36-44
34. Ohmori T, Abekawa T, Muraki A, Koyama T (1994) Competitive and noncompetitive NMDA antagonists block sensitization to methamphetamine. Pharmacol Biochem Behav 48: 587-591
35. Papa SM, Engber TM, Boldry RC, Chase TN (1993) Opposite effects of NMDA and AMPA receptor blockade on catalepsy induced by dopamine receptor antagonists. Eur J Pharmacol 232: 247-253
36. Paulson PE, Robinson TE (1996) Regional differences in the effects of amphetamine withdrawal on dopamine dynamics in the striatum. Analysis of circadian patterns using automated on-line microdialysis. Neuropsychopharmacology 14:325-337
37. Pierce RC, Bell K, Duffy P, Kalivas PW (1996) Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16: 1550-1560
38. Pulvirenti L, Swerdlow NR, Koob GF (1989) Microinjection of a glutamate antagonist into the nucleus accumbens reduces psychostimulant locomotion in rats. Neurosci Lett 103: 213-218
39. Ricardo JR (1980) Efferent connections of the subthalamic region in the rat. I. The subthalamic nucleus of Luys. Brain Res 202: 257-271
40. Robinson TE, Becker JB (1982) Behavioral sensitization is accompanied by an enhancement in amphetamine-stimulated dopamine release from striatal tissue in vitro. Eur J Pharmacol 85: 253-254
41. Robinson TE, Berridge KC (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18: 247-291
42. Scarnati E. Proia A, Campana E. Pacitti C (1986) A microiontophoretic study on the nature of the putative synaptic neurotransmitter involved in the pedunculopontine-substantia nigra pars compacta excitatory pathway of the rat. Exp Brain Res 62: 470-478
43. Schenk S, Valadez, A, McNamara C, House DT, Higley D. Bankson MG, Gibbs S, Horger BA (1993a) Development and expression of sensitization to cocaine's reinforcing properties: role of NMDA receptors. Psychopharmacology 111: 332-338
44. Schenk S. Valadez A, Worley CM, McNamara C (1993b) Blockade of the acquisition of cocaine self-administration by the NMDA antagonist MK-801 (dizocilpine). Behav Pharmacol 4: 652-659
45. Segal DS, Kuczenski R (1987) Behavioral and neurochemical characteristics of stimulant-induced augmentation. Psychopharmacol Bull 23: 417-424
46. Segal DS, Kuczenski R, Florin SM (1995) Does dizocilpine (MK-801) selectively block the enhanced responsiveness to repeated amphetamine administration? Behav Neurosci 109: 532-546
47. Sesack SR, Pickel VM (1992) Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral legmental area. J Comp Neurol 320: 145-160
48. Sharp T, Zetterström T, Ljungberg T, Ungerstedt U (1987) A direct comparison of amphetamine-induced behaviours and regional brain dopamine release in the rat using intracerebral dialysis. Brain Res 401: 322-330
49. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247: 571-574
50. Shoaib M. Shippenberg TS, Goldberg SR, Schindler CW (1996) Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behav Pharmacol 6: 568-576
51. Smith ID, Grace AA (1992) Role of the subthalamic nucleus in the regulation of nigral dopamine neuron activity. Synapse 12: 287-303
52. Stewart J. Druhan JP (1993) Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist. MK-801. Psychopharmacology 110: 125-132
53. Supko DE, Wallace LJ (1992) AMPA glutamate receptor activation in the posterior zona incerta inhibits amphetamine- and apomorphine-induced stereotypy. Brain Res 584: 213-218
54. Supko DE, Uretsky NJ, Wallace LJ (1992) AMPA/kainic acid glutamate receptor antagonism in the zona incerta dorsal to the subthalamic nucleus inhibits amphetamine-induced stereotypy but not locomotor activity. Brain Res 576: 89-96
55. Swedberg MDB, Jacobsen P. Honoré T (1995) Anticonvulsant, anxiolytic and discriminative effects of the AMPA antagonist 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo(f)quinoxaline (NBQX) J Pharmacol Exp Ther 274: 1113-1121
56. Ujike H, Tsuchida H, Kanzaki A, Akiyama K, Otsuki S (1992) Competitive and non-competitive N-methyl-D-aspartate antagonists fail to prevent the induction of methamphetamine-induced sensitization. Lite Sci 50: 1673-1681
57. Vezina P, Stewart J (1990) Amphetamine administered to the ventral tegmental area hut not to the nucleus accumbens sensitizes rats to systemic morphine; lack of conditioned effects. Brain Res 516: 99-106
58. Wedzony K, Czyrak A (1994) The role of corticosteroids in the acquisition of sensitization to locomotor stimulant effects of MK-801. Brain Res 657: 351-356
59. Wedzony K, Golembiowska K, Klimek V (1993) MK-801-induced symptoms of sensitization. The lack of correlation with the extracellular concentration of dopamine in the rat prefrontal cortex. Brain Res 625: 333-336
60. White FJ, Hu X-T, Henry DJ, Zhang X-F (1995a) Neurophysiological alterations in the mesoaccumbens dopamine system during repeated cocaine administration. In: Hammer RP Jr (ed) The neurobiology of cocaine: cellular and molecular mechanisms. CRC Press. Boca Raton. pp 95-115
61. White FJ, Hu X-T, Zhang X-F, Wolf ME (1995b) Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273: 445-454
62. Willins DL, Wallace LJ, Miller DD, Uretsky NJ (1992) α-Amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonists in the nucleus accumbens and ventral pallidum decrease the hypermotility response to psychostimulant drusis. J Pharmacol Exp Ther 260: 1145-1151
63. Wise RA, Mendrek A, Carlezon WA Jr (1996) MK-801 (dizocilpine): synergist and conditioned stimulus in bromocriptine-induced psychomotor sensitization. Synapse 22: 362-368
64. Wolf ME, Jeziorski M (1993) Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613: 291-294
65. Wolf ME, Khansa MR (1991) Repeated administration of MK-801 produces sensitization to its own locomotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562: 164-168
66. Wolf ME, White FJ, Hu X-T (1993) Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav Pharmacol 4: 429-442
67. Wolf ME, White FJ, Hu X-T (1994) MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14: 1735-1745
68. Wolf ME, Dahlin SL, Hu X-T, Xue C-J, White K (1995) Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69: 417-139
69. Zhang X-F, Hu X-T, White FJ, Wolf JE (1997) Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281: 699-706